Dr. Seng-Ho Jeon holds a Ph.D. in Pharmaceutical Sciences from Yonsei University, an MBA from Aalto University School of Business, a Master’s degree in Pharmaceutical Sciences from Seoul National University, and a Bachelor’s degree in Pharmacy from Seoul National University. He served as CEO and President of Daewoong Pharmaceutical from 2018 to 2024, where he led the company’s growth and global expansion. He also held concurrent leadership roles, including CEO of Affycell Therapeutics (2020 to April 2024) and CEO of Daewoong Investment (2023 to April 2024). In addition, he has been serving as a board member of Korea Science & Technology Holdings since 2023, and as an advisor and board member at the Future Medicine Research Foundation since 2021.